Safety and Effectiveness of Slow Wave Device for the Treatment of Obstructive Sleep Apnea
Part of paid clinical trials in Austin, Texas.
- Sponsor
- Slow Wave, Inc.
- Study ID
- NCT06519149
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Slow Wave UASD — DEVICEAn oral appliance for the treatment of OSA and snoring
Study Details
This is a safety and efficacy trial for a Slow Wave, Inc. UASD oral appliance for the treatment of Obstructive Sleep Apnea. This trial will recruit 60-80 participants through our IRB partner. Each participant will take pre-trial and post trail sleep studies and be measured before, throughout and after the trial for Apnea-Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), pulse rate to determine level of sleep improvement while wearing the device. Safety will also be measured through survey, dental exams and adverse events monitoring. Patients will wear an O2 monitoring ring throughout the study and upload results daily. Primary Objectives will evaluate AHI and ODI between sleep studies. Secondary outcomes will compare the daily ring data to these two sleep studies to evaluate changes over time. Patients will have the opportunity to complete daily diaries on their sleep experiences.
Key Dates
- Start date
- Oct 1, 2024
- Status verified
- Apr 2025
- Primary completion
- Aug 21, 2025
- Completion
- Sep 30, 2025
Study Design
- Enrollment
- 70 participants (estimated)
Arms
- Arm: Slow Wave UASDParticipants who wear the Slow Wave UASD oral device fora 90 day period and a Wellue O2 ring to measure daily sleep metrics
Primary Outcome Measure
AHI Events per hour [ Time Frame: 90 days ]
Central Contacts
- Bill S Morris5124663977
- Wayne R Wagner2817875589
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Austin Heart Research | Austin | Texas | 78705 |
Find similar trials in Austin, TX
Related Studies
- Pediatric Post-Approval RegistryRecruiting · Inspire Medical Systems, Inc. · Aurora, Colorado
- Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)Recruiting · Oregon Health and Science University · Aurora, Colorado
- Severe Label Expansion for EVO Products TrialRecruiting · ProSomnus Sleep Technologies · New York, New York
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure TherapyPHASE3 · Recruiting · Amgen · Northridge, California